Short stature homeobox gene mutation – Basic Information

Go back

Short stature homeobox gene mutation refers to genetic changes affecting the SHOX gene, a crucial component in bone development that can lead to various degrees of growth problems and skeletal differences in affected individuals.

Understanding SHOX Gene and Its Importance

The SHOX gene, short for short stature homeobox-containing gene, provides instructions for making a protein that acts as a transcription factor, which means it controls the activity of other genes. This gene belongs to a large family of homeobox genes that work during early development in the womb to control how many body structures form. The SHOX gene is particularly essential for skeletal development, playing a critical role in how bones in the arms and legs grow and mature.[1]

What makes the SHOX gene unique is its location on the sex chromosomes. One copy sits on the X chromosome and one on the Y chromosome, specifically in an area called the pseudoautosomal region. Unlike most genes that exist only on either the X or Y chromosome, genes in this special region appear on both. This means that both females, who have two X chromosomes, and males, who have one X and one Y chromosome, typically have two working copies of the SHOX gene in each cell.[1]

Epidemiology

SHOX gene deficiency represents a relatively common genetic cause of short stature in children. Research suggests that SHOX deficiency may account for approximately two to fifteen percent of short stature cases in children, though exact figures vary across different populations and studies.[16]

The prevalence of Léri-Weill dyschondrosteosis, one of the conditions caused by SHOX mutations, has been estimated to affect approximately one in 1,000 to 2,000 individuals in the general population, though this may be an underestimate since many cases remain undiagnosed.[2] The condition affects both males and females, though some features like Madelung deformity tend to be more common and severe in females.[3]

SHOX deficiency can occur in people of all ethnic backgrounds. The gene was first discovered during research into why women with Turner syndrome experience short stature, highlighting its fundamental role in normal growth.[2] Since its discovery in the 1990s, more than 380 different SHOX gene mutations have been identified throughout the gene’s coding regions, distributed across diverse populations worldwide.[9]

Causes

SHOX deficiency disorders arise from problems with the SHOX gene that result in insufficient amounts of the SHOX protein being produced. This insufficient production, called haploinsufficiency, can occur through several different mechanisms.[3]

The most common cause is a deletion, where the entire SHOX gene or a portion of it is missing. These deletions account for the majority of SHOX deficiency cases. Deletions can affect just the gene itself or may include nearby genetic material that normally helps control when and how much of the SHOX protein gets made.[1]

Point mutations represent another cause of SHOX deficiency. These are changes in the gene’s DNA sequence that can disrupt how the protein is made or how it functions. Some mutations create a premature stop signal during protein production, resulting in a shortened, non-functional protein. Other mutations may change critical parts of the protein that affect its ability to do its job properly.[1]

⚠️ Important
The severity of SHOX deficiency depends on how many gene copies are affected. When one copy of the SHOX gene has a mutation or deletion, it typically causes milder conditions like Léri-Weill dyschondrosteosis or idiopathic short stature. When both copies are affected, it results in the more severe Langer mesomelic dysplasia, characterized by very short stature and more pronounced skeletal abnormalities.

The genetic changes can also involve regulatory regions near the gene. These regions don’t code for the protein itself but control how much protein gets made. Deletions or changes in these control regions can reduce SHOX protein production even though the gene itself remains intact.[1]

Risk Factors

The primary risk factor for SHOX deficiency is having a parent with a SHOX gene mutation or deletion. SHOX deficiency disorders are inherited in what scientists call a pseudoautosomal dominant manner. This means that if one parent has a SHOX pathogenic variant, there is a fifty percent chance of passing it to each child, regardless of whether that child is male or female.[3]

If both parents carry SHOX deficiency, the risk calculations change significantly. Their offspring has a fifty percent chance of developing SHOX deficiency disorder similar to the parents, a twenty-five percent chance of developing the more severe Langer mesomelic dysplasia from inheriting mutations from both parents, and a twenty-five percent chance of not inheriting any SHOX mutations at all.[4]

Family history plays a crucial role in identifying risk. Multiple family members across generations may show signs of short stature or skeletal differences, though the severity can vary considerably even within the same family. Some individuals with SHOX mutations may have such mild features that they were never diagnosed, only becoming apparent when a child in the family shows more pronounced symptoms.[3]

Females with Turner syndrome face an increased risk of SHOX-related short stature. Turner syndrome occurs when one X chromosome is missing or structurally altered, meaning affected females have only one copy of the SHOX gene instead of the usual two. This loss contributes significantly to the short stature and skeletal abnormalities commonly seen in Turner syndrome.[1]

Conversely, individuals with extra sex chromosomes may have increased copies of the SHOX gene. Conditions such as triple X syndrome in females, XYY syndrome in males, or Klinefelter syndrome may result in taller stature due to the additional SHOX gene copies producing more protein than usual.[2]

Symptoms

The symptoms of SHOX deficiency vary widely depending on the specific genetic change and how severely it affects protein production. The spectrum ranges from mild, non-specific short stature to more pronounced skeletal abnormalities with characteristic features.[3]

Short stature compared to children of the same age and sex is the most consistent feature across all SHOX deficiency disorders. This shorter height often becomes more noticeable during school-age years, though some children may be identified earlier if their growth falls significantly below expected levels for their family.[4]

In Léri-Weill dyschondrosteosis, the classic presentation includes three main features: short stature, mesomelia, and Madelung deformity. Mesomelia refers to shortening of the middle portions of the limbs in relation to the upper portions, meaning the forearms and lower legs are disproportionately short compared to the upper arms and thighs. This feature can become evident first in school-aged children and typically increases in both frequency and severity with age.[3]

Madelung deformity affects the wrist and forearm bones, causing abnormal alignment of the radius, ulna, and carpal bones. This deformity typically develops during mid-to-late childhood and adolescence. It occurs more commonly and tends to be more severe in females. When present on both sides, Madelung deformity may cause discomfort or pain, particularly during activities that strain the wrist such as lifting, gripping, writing, or typing.[3]

Additional skeletal features may include elbows turned outward, knees turned inward, and bowing of the shinbones. Some affected individuals have short feet, a short neck, and a small lower jaw. The roof of the mouth may be unusually high and narrow, a feature called a high palate. Atypical curvature of the spine may also occur.[4]

Increased muscle mass represents another feature that can appear in people with SHOX deficiency, giving a stockier appearance to the body build.[4] Some individuals may have shortened arm span, where the distance from fingertip to fingertip with arms outstretched is less than their height, which is opposite to the typical pattern.[9]

In Langer mesomelic dysplasia, the most severe form of SHOX deficiency occurring when both gene copies are affected, symptoms include very short stature and extreme shortening of the long bones in the arms and legs. The skeletal abnormalities are similar to those in Léri-Weill dyschondrosteosis but significantly more pronounced.[1]

In less severe cases, sometimes called SHOX-deficient short stature or idiopathic short stature associated with SHOX deficiency, the presentation may be highly variable. Some individuals have short stature as their only noticeable feature, while others may have subtle skeletal abnormalities that might not be immediately obvious without careful examination.[3]

Rarely, hearing loss has been reported in some patients with SHOX deficiency, particularly in cases of Langer mesomelic dysplasia, though this is not a common or well-established feature of the condition.[5]

Prevention

Since SHOX deficiency is a genetic condition caused by inherited or spontaneous mutations in the SHOX gene, there is no known way to prevent the genetic changes themselves. However, several approaches can help identify the condition early and manage its effects more effectively.

Genetic counseling represents an important preventive measure for families with a history of SHOX deficiency. When one or both parents have a SHOX mutation, genetic counseling can help them understand the risks of passing the condition to their children. Counselors can explain inheritance patterns, recurrence risks, and available testing options for family members.[3]

Presymptomatic diagnosis and treatment are valuable for siblings at risk for SHOX-deficient short stature. Identifying affected children as early as possible allows healthcare providers to begin growth hormone treatment during childhood when it can be most effective. Early identification can result in better height outcomes and may help families plan appropriate support and interventions.[3]

Regular growth monitoring serves as an important screening tool. Healthcare providers should track children’s growth carefully, plotting height measurements on growth charts during routine check-ups. When a child’s growth pattern shows concerning features such as falling across two percentile lines or having disproportionate limb lengths, further evaluation including SHOX gene testing may be warranted.[3]

For individuals diagnosed with SHOX deficiency who develop Madelung deformity, certain preventive strategies may help manage discomfort and slow progression. Limiting physical activities that strain the wrist, such as heavy lifting, repetitive gripping, or sports that put excessive stress on the wrist joints, may help prevent worsening of symptoms. Using ergonomic devices like specially designed computer keyboards can also reduce strain during daily activities.[3]

⚠️ Important
Families with known SHOX deficiency should consider genetic testing for at-risk relatives, particularly children who show signs of short stature or skeletal abnormalities. Early diagnosis allows for timely intervention with growth hormone therapy, which is most effective when started during prepubertal years before growth plates close.

While the genetic condition itself cannot be prevented, awareness and early detection combined with appropriate medical management can significantly improve outcomes and quality of life for affected individuals.

Pathophysiology

The SHOX gene functions as a transcription factor, meaning the protein it produces controls the activity of other genes by binding to specific DNA sequences and regulating whether those genes are turned on or off. During embryonic development, the SHOX protein plays a particularly important role in skeletal formation, especially in the development of long bones in the arms and legs.[1]

The SHOX protein is specifically expressed in developing limb structures and pharyngeal arches during early human embryonic development. It acts as a regulator of cellular processes in the growth plate, the area of developing tissue near the ends of long bones where new bone is produced during childhood and adolescence. The protein helps control both the multiplication of cartilage cells called chondrocytes and their maturation into bone cells.[9]

When SHOX gene mutations or deletions occur, the amount of functional SHOX protein available in cells decreases. This reduction disrupts the normal signaling pathways that control bone growth and development. Without adequate SHOX protein, the carefully orchestrated process of bone formation and elongation becomes impaired, starting even before birth and continuing throughout the growth years.[1]

The severity of skeletal abnormalities directly relates to how much functional SHOX protein remains available. When one copy of the gene is affected, approximately half the normal amount of protein is produced. This reduction is sufficient to cause the milder to moderate features seen in Léri-Weill dyschondrosteosis or idiopathic short stature associated with SHOX deficiency. The remaining functional copy cannot fully compensate for the loss, resulting in observable growth and skeletal differences.[3]

When both copies of the SHOX gene are affected, as occurs in Langer mesomelic dysplasia, SHOX protein production is greatly reduced or eliminated entirely. This more complete loss of protein function leads to much more severe disruption of bone development, resulting in very short stature and pronounced skeletal abnormalities including extreme limb shortening.[1]

The timing of SHOX protein activity explains why different skeletal regions are affected. The protein is most active during specific developmental windows when bones are forming and growing. The long bones of the arms and legs, particularly the radius and ulna in the forearm and the tibia and fibula in the lower leg, are especially sensitive to SHOX protein levels. This explains why mesomelia and Madelung deformity are characteristic features of SHOX deficiency.[3]

Madelung deformity develops because of differential growth rates in the radius and ulna bones of the forearm. When SHOX protein is insufficient, the radius does not grow normally, particularly on its ulnar side. This creates an abnormal angle and positioning of the wrist joint, leading to the characteristic deformity that typically becomes more pronounced during adolescent growth spurts.[3]

Research has shown that the SHOX gene has been highly conserved across evolution, with similar genes present in various animals, insects, and fish. This conservation suggests the gene performs fundamental functions in skeletal development across many species. The pseudoautosomal location of the gene, present on both sex chromosomes, means it escapes the normal X-inactivation process that silences most genes on one X chromosome in females, explaining why both males and females with the same mutation typically show similar features.[2]

Ongoing Clinical Trials on Short stature homeobox gene mutation

References

https://medlineplus.gov/genetics/gene/shox/

https://en.wikipedia.org/wiki/Short-stature_homeobox_gene

https://www.ncbi.nlm.nih.gov/books/NBK1215/

https://www.medicalnewstoday.com/articles/shox-syndrome

https://jcrpe.org/articles/detection-of-lessigreatershoxlessigreater-gene-variations-in-patients-with-skeletal-abnormalities-with-or-without-short-stature/jcrpe.galenos.2020.2019.0001

https://omim.org/entry/312865

https://pubmed.ncbi.nlm.nih.gov/17047016/

https://www.ncbi.nlm.nih.gov/books/NBK1215/

https://e-apem.org/m/journal/view.php?number=587

https://medlineplus.gov/genetics/gene/shox/

https://e-apem.org/journal/view.php?number=1043

https://www.medicalnewstoday.com/articles/shox-syndrome

https://www.medicalnewstoday.com/articles/shox-syndrome

https://www.wakemed.org/blog/when-worry-about-your-childs-height-insights-pediatric-endocrinologist-mark-henin-md

https://pmc.ncbi.nlm.nih.gov/articles/PMC10305486/

https://pmc.ncbi.nlm.nih.gov/articles/PMC5602651/

FAQ

Can SHOX deficiency be cured?

SHOX deficiency cannot be cured as it is a genetic condition present from birth. However, treatment with recombinant human growth hormone during childhood can improve final adult height by approximately 7 to 10 centimeters, and various supportive measures can help manage skeletal symptoms.

How is SHOX deficiency diagnosed?

Diagnosis is established through genetic testing that identifies either a pathogenic SHOX gene variant, deletion, duplication, or insertion affecting the SHOX gene or its regulatory regions. Clinical features such as short stature, disproportionate limb shortening, or Madelung deformity typically prompt doctors to order this genetic testing.

Will my child with SHOX deficiency need growth hormone treatment?

Growth hormone therapy is recommended for prepubertal children with SHOX-deficient short stature. Treatment should be started before puberty and continued until growth plates close. The decision involves careful discussion with a pediatric endocrinologist about potential benefits and the commitment to daily injections.

Is SHOX deficiency the same as Turner syndrome?

No, they are different conditions, though related. Turner syndrome is a chromosomal condition where females are missing or have an altered X chromosome, resulting in only one copy of the SHOX gene. This contributes to the short stature seen in Turner syndrome, but Turner syndrome involves many other features beyond SHOX deficiency alone.

If I have SHOX deficiency, what are the chances my children will have it?

If one parent has SHOX deficiency, each child has a 50% chance of inheriting the condition, regardless of whether the child is male or female. If both parents have SHOX deficiency, children have a 50% chance of inheriting one mutation, a 25% chance of inheriting mutations from both parents (resulting in more severe Langer mesomelic dysplasia), and a 25% chance of not inheriting any mutations.

🎯 Key takeaways

  • SHOX gene deficiency accounts for 2-15% of short stature cases in children, making it one of the more common genetic causes of growth problems
  • The severity of symptoms depends on how many SHOX gene copies are affected, ranging from mild short stature to severe skeletal abnormalities
  • Growth hormone therapy can increase final adult height by 7-10 centimeters when started during childhood before puberty
  • The SHOX gene uniquely exists on both X and Y chromosomes in the pseudoautosomal region, meaning both males and females have two functional copies
  • Madelung deformity of the wrist develops more commonly and severely in females with SHOX deficiency, typically appearing in mid-to-late childhood
  • More than 380 different SHOX gene mutations have been identified worldwide, distributed throughout the gene’s coding regions
  • Early genetic diagnosis allows families to begin appropriate treatment during the most effective window and helps with family planning through genetic counseling
  • Having extra copies of the SHOX gene, as occurs in some sex chromosome conditions, can actually result in increased rather than decreased stature

Connected medications: